Webinar scheduled for June 14, 2022 at 5:00 p.m. ETCLEVELAND (BUSINESS WIRE) $ATHX #investorconference Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a panel discussion with leading neurology experts.
Athersys Hosting KOL Panel Event to Discuss TREASURE Data streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Stock Market | Daily Herald dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.
2022 MAY 17 By a News Reporter-Staff News Editor at NewsRx Hematology Daily Researchers detail new data in Heart Disorders and Diseases- Patent Foramen Ovale. According to news originating from Goyang, South Korea, by NewsRx correspondents, research stated,“ Paradoxical embolism from venous thrombosis through the patent foramen ovale is a rare but.